Impact of <scp>340B</scp> Exposure on Treatment Utilization and Cost for Medicare Patients With Cancer
Findings are consistent with the financial incentives of the 340B program and highlight that the program has a broad impact on patient care and cost. Policymakers should consider ways to support safety net providers that are not tied to outpatient medications.
Authors
- Danea Horn (ORCID: https://orcid.org/0000-0002-9746-4893)
- Kevin Alan Schulman (ORCID: https://orcid.org/0000-0002-8926-5085)
Institutions
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Health Services Research
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/1475-6773.70092
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00